297. Enhertu, Xeloda, and Living with De Novo Metastatic Breast Cancer: Annick’s Story

Love the podcast? Send us a text! In this episode of Breast Cancer Conversations , host Laura Carfang speaks with Annick Pyfferoen about her experience being diagnosed with de novo metastatic breast cancer and navigating several lines of treatment including targeted therapy, chemotherapy, a clinical trial attempt involving tumor-infiltrating lymphocytes, Enhertu, and Xeloda. She speaks openly about what it felt like to experience rapid progression and why having a plan, even one that may change, helps her navigate uncertainty. This episode is a reminder that metastatic breast cancer care is not only about what is happening on scans. It is also about communication, side effect management, informed decision-making, emotional support, and helping people live as well as possible for as long as possible. Support the show Listener Feedback Please share a review with us! If this episode resonated with you, we invite you to leave a review on Apple Podcasts or Spotify and share some stars! You can also click the link in the show notes that says "Love this episode? Send us a text" to share feedback. Messages are completely anonymous. If you would like us to follow up directly, please include your email address in your message so we can respond. Latest News: Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources from SurvivingBReastCancer.org! Enjoying our content? Please consider supporting our work .